Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-002911
Filing Date
2025-05-12
Accepted
2025-05-12 16:29:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3304
  Complete submission text file 0001950047-25-002911.txt   4894
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37553 | Film No.: 25935294
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Mills Kenneth T. (Reporting) CIK: 0001652824 (see all company filings)

Type: 144